Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Return of sore throat, congestion, positive Covid test; This spontaneous case was reported by a non-health professional and describes the occurrence of COVID-19 (Return of sore throat, congestion, positive Covid test) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     The patient's past medical history included Pleurectomy, Diaphragm resection and Lung wedge resection. Concurrent medical conditions included Graves' disease and Drug allergy. Concomitant products included OMEPRAZOLE from 01-Jun-2021 to an unknown date, FISH OIL from 01-Jun-2021 to an unknown date, ACETYLSALICYLIC ACID (BABY ASPIRIN) from 01-Jun-2021 to an unknown date, MULTIVITAMINS [VITAMINS NOS] from 01-Jun-2021 to an unknown date and MAGNESIUM from 01-Jun-2021 to an unknown date for an unknown indication.    On 21-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Return of sore throat, congestion, positive Covid test). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 20-May-2022 to 25-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (Return of sore throat, congestion, positive Covid test) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-May-2022, SARS-CoV-2 test: positive (Positive) positive. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         Patient had return of sore throat, congestion, positive COVID test. Concomitant medication include butterbu Patient had taken any other medications/products within 2 weeks of starting COVID-19 treatment. Patient previously received a COVID-19 Vaccine.  Device Date : 31May2022  Company comment: This is a spontaneous case concerning a patient of unknown age and gender with no relevant medical history, who experienced the unexpected non-serious event of Covid-19. The event occurred approximately 6 months after the third dose of mRNA-1273 vaccine administration. The event was described as, approximately 180 days after the third dose of mRNA-1273 vaccine, patient took Nirmatrelvir + Rotinavir (Paxlovid) for treatment of Covid-19. However, approximately 4 days after the last dose of Nirmatrelvir + Rotinavir (Paxlovid), patient experienced return of sore throat and congestion with positive Covid test. No other information surrounding the event was reported. The outcome of the event was reported as resolving. The current Covid-19 pandemic remain confounder for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient of unknown age and gender with no relevant medical history, who experienced the unexpected non-serious event of Covid-19. The event occurred approximately 6 months after the third dose of mRNA-1273 vaccine administration. The event was described as, approximately 180 days after the third dose of mRNA-1273 vaccine, patient took Nirmatrelvir + Rotinavir (Paxlovid) for treatment of Covid-19. However, approximately 4 days after the last dose of Nirmatrelvir + Rotinavir (Paxlovid), patient experienced return of sore throat and congestion with positive Covid test. No other information surrounding the event was reported. The outcome of the event was reported as resolving. The current Covid-19 pandemic remain confounder for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.